Short Interest Coverage: What’s Wright Medical Group N.V (NASDAQ:WMGI) Upside After This Short Interest Decrease?

November 21, 2016 - By Ellis Scott   ·   0 Comments

Short Interest Coverage: What's Wright Medical Group N.V (NASDAQ:WMGI) Upside After This Short Interest Decrease?

The stock of Wright Medical Group N.V (NASDAQ:WMGI) registered a decrease of 5.06% in short interest. WMGI’s total short interest was 11.17 million shares in November as published by FINRA. Its down 5.06% from 11.76 million shares, reported previously. With 811,000 shares average volume, it will take short sellers 14 days to cover their WMGI’s short positions. The short interest to Wright Medical Group N.V’s float is 11.98%. About 123,111 shares traded hands. Wright Medical Group Inc (NASDAQ:WMGI) has risen 24.46% since April 19, 2016 and is uptrending. It has outperformed by 20.60% the S&P500.

Wright Medical Group, Inc. is a global specialty orthopaedic company. The company has a market cap of $1.23 billion. The Firm through Wright Medical Technology, Inc. and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. It currently has negative earnings. The Firm operates through three divisions: U.S., International and BioMimetic.

Wright Medical Group Inc (NASDAQ:WMGI) Ratings Coverage

Out of 14 analysts covering Wright Medical Group (NASDAQ:WMGI), 12 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 86% are positive. Wright Medical Group has been the topic of 17 analyst reports since August 20, 2015 according to StockzIntelligence Inc. Needham upgraded it to “Buy” rating and $22 target price in Monday, February 22 report. On Thursday, June 9 the stock rating was initiated by Guggenheim with “Buy”. JP Morgan upgraded it to “Overweight” rating and $26 target price in Wednesday, July 13 report. The stock has “Outperform” rating given by Leerink Swann on Thursday, September 3. The rating was maintained by Northland Capital with “Buy” on Wednesday, September 2. As per Monday, November 30, the company rating was maintained by Oppenheimer. The rating was upgraded by Jefferies to “Buy” on Monday, November 30. The company was initiated on Monday, April 11 by Bank of America. On Thursday, August 20 the stock rating was maintained by Needham with “Hold”. The rating was maintained by Needham with “Hold” on Thursday, September 3.

WMGI Company Profile

Wright Medical Group N.V., formerly Tornier N.V., is a medical device company. The Firm is focused on extremities and biologics products. The Firm operates through the orthopaedic products segment, which includes the design, manufacture, marketing and sales of extremities, biologics, large joint and other products. The Firm offers a product portfolio of over 160 extremities products and approximately 20 biologics products that are designed to provide solutions to its surgeon customers. The Company’s product portfolio consists of product categories, which include upper extremities, lower extremities, biologics, sports medicine and other, and large joints.

More notable recent Wright Medical Group Inc (NASDAQ:WMGI) news were published by: which released: “Wright Medical Group N.V. Announces Private Placement of $395 Million of 2.25 …” on May 13, 2016, also with their article: “Wright Medical Group N.V. Announces Binding Offer Under Which Corin …” published on July 11, 2016, published: “Jefferies Says Wright Medical A Top Pick, Management Meetings ‘Heartening'” on August 12, 2016. More interesting news about Wright Medical Group Inc (NASDAQ:WMGI) were released by: and their article: “Wright Medical Group N.V. Reports 2016 Second Quarter Financial Results and …” published on August 02, 2016 as well as‘s news article titled: “Wright Medical Group N.V. to Present at 2016 Wells Fargo Healthcare Conference” with publication date: August 18, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Ellis Scott

Readers Comments (0)

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News